Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Rectal cancer
Stage/Subtype:  stage II rectal cancer
Country:  U.S.A.
Trial Type:  Treatment
Results 1-15 of 15 for your search:
Start Over
Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery
Status: Active
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: N1048, NCI-2012-00234, CDR0000715321, NCCTG-N1048, PN1048_A11PAMDREVW01, NCT01515787
Efficacy and Safety of LifeSeal™ Kit for Colorectal Staple Line Sealing
Status: Active
Phase: Phase III
Type: Treatment
Age: 21 and over
Trial IDs: CLP-LS-0131, NCI-2017-00410, NCT02907385
Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin before Surgery in Treating Patients with Stage II-III Rectal Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 3R-12-2, NCI-2013-01069, 3C-12-2, HS-12-00726, ML28263, NCT01871571
Chemotherapy before or after Chemoradiation Followed by Surgery or Non-operative Management in Treating Patients with Previously Untreated Stage II-III Rectal Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13-213, NCI-2013-02356, NCT02008656
Low Dose Whole Pelvic Radiation Therapy and Fluorouracil, Leucovorin Calcium, and Oxaliplatin in Treating Patients with Newly Diagnosed Stage IIIA-IIIB Rectal Cancer That Can Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: GCC 1314, NCI-2015-02142, 1314GCC, 15654748, HP-00060641, NCT02319304
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: S1609, NCI-2016-01041, NCT02834013
Veliparib and Combination Chemotherapy in Treating Patient with Locally Advanced Rectal Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: NRG-GI002, NCI-2016-00222, NCT02921256
An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib
Status: Enrolling by invitation
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: INCB 18424-270, NCI-2017-00377, NCT02955940
Trametinib, Fluorouracil, and Radiation Therapy before Surgery in Treating Patients with Stage II-III Rectal Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: OSU-12054, NCI-2012-02158, 2012C0086, NCT01740648
Niclosamide in Treating Patients with Colon Cancer That Can Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: Pro00066964, NCI-2016-01245, NCT02687009
hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: TRT-001, NCI-2017-00011, NCT02960594
Chinese Herbal Formulation PHY906 in Reducing Side Effects Caused by Capecitabine and Radiation Therapy in Patients with Locally Advanced Rectal Cancer
Status: Active
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 1404013708, NCI-2014-01560, NCT02178644
A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection
Status: Active
Phase: No phase specified
Type: Diagnostic, Treatment
Age: 18 and older
Trial IDs: PP PLR 03, NCI-2015-01386, NCT02205307
Epigallocatechin Gallate in Treating Patients with Colorectal Cancer That Can Be Removed by Surgery
Status: Active
Phase: No phase specified
Type: Prevention, Treatment
Age: 18 and over
Trial IDs: CTMS# 16-0085, NCI-2016-01852, HSC20160446H, NCT02891538
A Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Techniques Plus Sylys® Surgical Sealant
Status: Active
Phase: No phase specified
Type: Treatment
Age: 22 and over
Trial IDs: PRO-106-0129, NCI-2017-00693, NCT02841891
Start Over